FIRST TRUST ADVISORS LP

Position in KYMR — Kymera Therapeutics, Inc.

CIK 1125816 Wheaton, IL

Position in KYMR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$7,037,068

-$760,291 QoQ

Shares Held

61,368

-34.4% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#87

of 275 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. KYMR ranks #53 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	547,132	$341,158,687
2	INCY	Incyte Corp	1,587,996	$180,015,226
3	CORT	Corcept Therapeutics Inc	1,829,545	$159,078,937
4	VRTX	Vertex Pharmaceuticals Inc / Ma	289,179	$143,643,884
5	EXEL	Exelixis, Inc.	2,543,353	$138,383,836
6	ALNY	Alnylam Pharmaceuticals, Inc.	421,534	$126,894,380
7	KRYS	Krystal Biotech, Inc.	324,900	$120,755,583
8	AXSM	Axsome Therapeutics, Inc.	482,061	$117,994,070

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,037,068	61,368	-34.4%	Shares	Sole	2026-08-11
2026-03-31	$7,797,359	93,617	+59.0%	Shares	Sole	2026-05-13
2025-12-31	$4,580,052	58,862	-21.4%	Shares	Sole	2026-02-13
2025-09-30	$4,236,623	74,852	-20.2%	Shares	Sole	2025-11-12
2025-03-31	$2,567,169	93,795	-46.8%	Shares	Sole	2025-05-14
2024-12-31	$7,089,330	176,220	+43.2%	Shares	Sole	2025-02-13
2024-09-30	$5,823,719	123,045	-11.2%	Shares	Sole	2024-11-13
2024-06-30	$4,138,284	138,636	+104.7%	Shares	Sole	2024-08-13
2024-03-31	$2,723,228	67,742	+154.8%	Shares	Sole	2024-05-13
2023-06-30	$611,327	26,591	-11.5%	Shares	Sole	2023-08-14
2022-06-30	$591,782	30,055	-45.1%	Shares	Sole	2022-08-12
2022-03-31	$2,315,284	54,709	-41.5%	Shares	Sole	2022-05-13
2021-12-31	$5,942,410	93,596	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.